Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
MTHABISI TALENT GEORGE MOYO
 -- 1401 2022-06-27 12:22:07 |
2 format correct
Nora Tang
 Meta information modification 1401 2022-06-28 08:19:51 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Akulo, K.A.;  Adali, T.;  Moyo, M.T.G.;  Bodamyali, T. Natural Polymer-Based Hydrogels for Glaucoma Therapy. Encyclopedia. Available online: https://encyclopedia.pub/entry/24507 (accessed on 16 November 2024).
Akulo KA,  Adali T,  Moyo MTG,  Bodamyali T. Natural Polymer-Based Hydrogels for Glaucoma Therapy. Encyclopedia. Available at: https://encyclopedia.pub/entry/24507. Accessed November 16, 2024.
Akulo, Kassahun Alula, Terin Adali, Mthabisi Talent George Moyo, Tüli̇n Bodamyali. "Natural Polymer-Based Hydrogels for Glaucoma Therapy" Encyclopedia, https://encyclopedia.pub/entry/24507 (accessed November 16, 2024).
Akulo, K.A.,  Adali, T.,  Moyo, M.T.G., & Bodamyali, T. (2022, June 27). Natural Polymer-Based Hydrogels for Glaucoma Therapy. In Encyclopedia. https://encyclopedia.pub/entry/24507
Akulo, Kassahun Alula, et al. "Natural Polymer-Based Hydrogels for Glaucoma Therapy." Encyclopedia. Web. 27 June, 2022.
Natural Polymer-Based Hydrogels for Glaucoma Therapy
Edit
This entry is adapted from the peer-reviewed paper 10.3390/polym14122359
Biopolymers have been extensively investigated in a number of medical fields, including tissue engineering and drug delivery. This is largely due to the fact that they are biodegradable within the body, and do not induce an inflammatory reaction. Polynucleotides such as nucleic acids (DNA and RNA), proteins such as polypeptides, and polyesters derived from both plants and animals are also used. When compared to synthetic polymers, naturally occurring biopolymers and their derivatives have acquired preference, and have a comprehensive range of applications in pharmaceutical as well as biomedical research. Natural biopolymers are preferred for medical applications due to their biodegradability, biostability, biocompatibility, and non-toxicity. Additionally, natural polymers have the advantage of being readily available, economically friendly, and ecofriendly. Hydrogels designed from natural polymers exhibit high potential as drug delivery systems for biomaterials to treat ocular impairments.
glaucoma natural biopolymers intravitreal injectable hydrogel drug delivery systems

1. Silk Fibroin

Bombyx mori silk is a natural biopolymer obtained from arthropods and lepidopteran insects, particularly silkworms and some spider groups, that produce silk fibers at large. Due to their remarkable mechanophysical and biological properties, silk fibers have attracted the interest of researchers [1], for biomedical and pharmaceutical applications. Silk fibroin is an essential biopolymer used in biomedical applications due to its adaptable properties, with a natural physiology that makes it preferable in the study of tissue reconstruction in age-related ocular disease [2]. Silk fibroin is a fibrous protein that exhibits favorable biocompatibility, bioresorbability, low immunogenicity, and hydrophilicity, promoting its increasing consideration in hydrogel design. It is also rich in β-sheet structures, owing to hydrophobic domains that influence its biodegradability rate [3], as well as its cytological compatibility [4]. Silk fibroin proteins have been used for ocular therapies such as wound healing [5], ocular drug delivery [6], and ocular prostheses [7].

2. Chitosan

Linear-structured chitosan is a natural biopolymer composed of an acetylated unit of N-acetyl-D-glucosamine and β-(1→4)-linked D-glucosamine, a deacetylated unit. It is prepared by treating chitin shrimp shells and various crustacean shells with sodium hydroxide [8].
Due to poly-oxy salt formation, chitosan exhibits basic properties different from those of other polysaccharides [9]. As with other polymers, chitosan can also form hydrogels, films, and particles that can be used for biomedical applications in terms of drug delivery units, tissue engineering, cell culturing, and platforms for cancer diagnosis. Its low toxicity, high biocompatibility, and easy degradability in a natural environment which makes it suitable as natural extracellular matrices [10].
According to surveys carried out by several researchers, the major constraint when working with injectable hydrogel preparations is regulating the time of gelation [11]. However, a chitosan-based formulation of injectable hydrogel was developed that regulates the time of gelation [12].
To be used as a biomaterial, chitosan has important properties that mimic the extracellular matrices of cells, tissues, and organs. Chitosan is prepared and used either in a dried form or in the form of gels, depending on the temperature used and the amount of water present in the structure, which impart properties of flexibility [13].
According to the study conducted by Franca, J.R. et al. [14], chitosan can be widely applied in the treatment of glaucoma-induced intraocular pressure, acting as a basis for controlled drug delivery in the eye. This is because chitosan is polycationic by its very nature, allowing interaction with the polyanionic surface through hydrogen bonding of the ocular mucosa. Chitosan has several biological properties that make it an attractive material for use in ocular formulations [15]. Chitosan has inherent antimicrobial and mucoadhesive properties [16], as well as low toxicity, biodegradability, biocompatibility, and hemocompatibility [17]. Chitosan can disrupt epithelial tight junctions, thus acting as a permeability enhancer [16].

3. Alginic Acid

Brown algae are the main source of the naturally derived polysaccharide alginic acid (Alg), with the molecular formula (C6H11NO6)n. The molecular structure and composition of alginic acid consist of L-guluronic acid and D-mannuronic acid structures connected with alpha-1,4 bonds [18]. As a result of the carboxyl group attached to the C-5 carbon as a chain, it exhibits an acidic nature, and with properties such high hydrophilicity, the capacity for gelation, and pH-dependent viscoelasticity. Furthermore, biocompatibility and biodegradability are some of the physiological properties that make it suitable for use as films and gels developed for medical and food applications [19]. Alginic acid has a biodegradable and biocompatible nature that is favorable for researchers; therefore, its use has been encouraged in ocular treatments [20]. Ocular delivery therapeutics are a current trend in ophthalmology, and alginates have been employed to play an imperative role because of their biocompatibility and immunogenicity [21].

4. Pullulan

Pullulan is a non-ionic polysaccharide extracted from the fermentation of black yeast (Aureobasidium pullulan), and is used broadly in biomedical applications because of its less immunogenic reaction, along with its non-toxic, non-mutagenic, and non-carcinogenic nature [22]. It is utilized in the targeted delivery of drug mechanisms, tissue engineering therapy, and wound-healing activities. Pullulan responds to external stimuli so that it can be used to design hydrogels, which can be used to deliver drugs, nutrients, and (any) other molecules to a targeted area of the host [23]. The biological properties of pullulan include high water retention, biocompatibility, cytocompatibility, protective activity against microbes and biodegradation, and tissue-regenerative characteristics [24].

5. Hyaluronic Acid

A biopolymer regularly found and extracted from the human body, applications of hyaluronic acid as injectable hydrogels have been researched for ocular drug delivery systems, since they can be designed as both stimulus-responsive and static [25]. Anionic hyaluronic acid is incapable of gelation without additive molecules. Hence, hydrogels produced using hyaluronic acid depend on chemical modifications. Egbu et al. formulated two hyaluronic acid gel systems embedded with infliximab for the treatment of blinding infections influencing the elderly population [26]. Hyaluronic acid has been applied in ocular therapeutics because of its favorable biological characteristics, such as biocompatibility, biodegradability, and non-immunogenicity [27]. Due to hyaluronic acid’s biological safety, it has various ophthalmology-related applications, such as treatment for dry eyes, intravitreal drug delivery, and use in contact lenses [27].
The main objective in the development of ophthalmic drug treatment is to extend the therapeutic extent of medications, particularly proteins and antibodies [28].

6. Dextran

Dextran methacrylate and cyclodextrin–dextran are a few examples of dextran hydrogels used in ocular drug delivery [29]. Properties such as stiffness, mechanical strength, and solidness can be adjusted by regulating the monomer in the gel, subsequently improving their significance in drug delivery. Yao et al. [30], designed a drug delivery system for effective in vivo drug release of bevacizumab from a hyaluronic acid/dextran-situated in situ hydrogel for 6 months after intravitreal infusion in hare eyes. The in vivo drug release efficiency results indicated that bevacizumab was delivered at a therapeutically relevant concentration by means of a controlled release mechanism within the vitreous humor [31]. Dextran has been found to exhibit great biocompatibility and low cytotoxicity. Additionally, it has hydrophilic domains, which promote its biodegradability in water and other organic solvents. This biological feature enables its applicability in blended forms with bioactive agents of hydrophobic polymers [32].

7. Methylcellulose

Derived from cellulose, hydroxypropyl methylcellulose (HMPC) is widely used in the pharmaceutical industry because of its solvency in water, rheological properties, and transparency [33]. A group of researchers designed a trans-scleral antisense oligonucleotide-loaded gel for the delivery of drug-loaded macromolecules using methylcellulose and ι-carrageenan dispersions [34]. Periocular injection of the gel resulted in impressive choroid and sclera bioavailability in comparison to the injection of an oligonucleotide solution alone. Methylcellulose has been incorporated into ocular inserts of three types: soluble, insoluble, and bio-erodible, [35]. Methylcellulose has low reactivity with cells. Additionally, interest has been shown in mixing it with biologically active materials such as cytokines and/or the extracellular matrix to control the organization or functions of the cells [36].

8. Gelatin

Gelatin is a collagen-derived biopolymer normally found in scleral and corneal stroma, and its structural networks make it an attractive natural complex for research applications. El-Feky et al. [37] developed an oxidized sucrose-crosslinked gelatin–chitosan hydrogel with the end goal of TM drug conveyance for the treatment and control of ocular hypertension [38]. In vivo and in vitro discoveries indicated that the formulated system maintained favorable release efficacy of the active ingredient, in contrast to the regular eye drops [39]. Gelatin has favorable biological characteristics such as low antigenicity, biocompatibility, and biodegradability, and promotes cell proliferation; therefore, it is widely researched in ophthalmologic therapeutics [40].

9. Collagen

Collagen is biocompatible, biodegradable, and non-toxic for living organisms [41]. Type 1 collagen is an essential biopolymer that has been utilized in hydrogels for tissue engineering applications [42]. Wong et al. [43] designed an injectable composite comprising collagen and alginate for retinal treatment through a drug delivery system loaded with an ocular drug. 

References

  1. Zhang, W.; Chen, L.; Chen, J.; Wang, L.; Gui, X.; Ran, J.; Xu, G.; Zhao, H.; Zeng, M.; Ji, J.; et al. Silk Fibroin Biomaterial Shows Safe and Effective Wound Healing in Animal Models and a Randomized Controlled Clinical Trial. Adv. Healthc. Mater. 2017, 6, 1700121.
  2. Suzuki, S.; Shadforth, A.; McLenachan, S.; Zhang, D.; Chen, S.-C.; Walshe, J.; Lidgerwood, G.; Pébay, A.; Chirila, T.V.; Chen, F.; et al. Optimization of silk fibroin membranes for retinal implantation. Mater. Sci. Eng. C 2019, 105, 110131.
  3. Tulay, P.; Galam, N.; Adali, T. The Wonders of Silk Fibroin Biomaterials in the Treatment of Breast Cancer. Crit. Rev. Eukaryot. Gene Expr. 2018, 28, 129–134.
  4. Galam, N.; Tulay, P.; Adali, T. In Vitro MCF-7 Cells Apoptosis Analysis of Carboplatin Loaded Silk Fibroin Particles. Molecules 2020, 25, 1110.
  5. Abdel-Naby, W.; Cole, B.; Liu, A.; Liu, J.; Wan, P.; Guaiquil, V.H.; Schreiner, R.; Infanger, D.; Lawrence, B.D.; Rosenblatt, M.I. Silk-derived protein enhances corneal epithelial migration, adhesion, and proliferation. Investig. Ophthalmol. Vis. Sci. 2017, 58, 1425–1433.
  6. Bhattacharjee, P.; Fernández-Pérez, J.; Ahearne, M. Potential for combined delivery of riboflavin and all-trans retinoic acid, from silk fibroin for corneal bioengineering. Mater. Sci. Eng. C 2019, 105, 110093.
  7. Applegate, M.B.; Partlow, B.P.; Coburn, J.; Marelli, B.; Pirie, C.; Pineda, R.; Kaplan, D.L.; Omenetto, F.G. Photocrosslinking of silk fibroin using riboflavin for ocular prostheses. Adv. Mater. 2016, 28, 2417–2420.
  8. Bakshi, P.S.; Selvakumar, D.; Kadirvelu, K.; Kumar, N.S. Chitosan as an environment friendly biomaterial—A review on recent modifications and applications. Int. J. Biol. Macromol. 2020, 150, 1072–1083.
  9. Kumorek, M.; Minisy, I.; Krunclová, T.; Voršiláková, M.; Venclíková, K.; Chánová, E.M.; Janoušková, O.; Kubies, D. pH-responsive and antibacterial properties of self-assembled multilayer films based on chitosan and tannic acid. Mater. Sci. Eng. C 2019, 109, 110493.
  10. Highley, C.B.; Rodell, C.B.; Burdick, J.A. Direct 3D Printing of Shear-Thinning Hydrogels into Self-Healing Hydrogels. Adv. Mater. 2015, 27, 5075–5079.
  11. Wang, H.; Shi, J.; Wang, Y.; Yin, Y.; Wang, L.; Liu, J.; Liu, Z.; Duan, C.; Zhu, P.; Wang, C. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Biomaterials 2014, 35, 3986–3998.
  12. Cho, I.S.; Park, C.G.; Huh, B.K.; Cho, M.O.; Khatun, Z.; Li, Z.; Kang, S.-W.; Bin Choy, Y.; Huh, K.M. Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy. Acta Biomater. 2016, 39, 124–132.
  13. Skwarczynska, A.L.; Binias, D.; Maniukiewicz, W.; Modrzejewska, Z.; Douglas, T.E. The mineralization effect on chitosan hydrogel structure containing collagen and alkaline phosphatase. J. Mol. Struct. 2019, 1187, 86–97.
  14. Franca, J.R.; Foureaux, G.; Fuscaldi, L.L.; Ribeiro, T.G.; Castilho, R.O.; Yoshida, M.I.; Cardoso, V.N.; Fernandes, S.O.; Cronemberger, S.; Nogueira, J.C.; et al. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation. Int. J. Pharm. 2019, 570, 118662.
  15. Kumirska, J.; Weinhold, M.X.; Thöming, J.; Stepnowski, P. Biomedical Activity of Chitin/Chitosan Based Materials—Influence of Physicochemical Properties Apart from Molecular Weight and Degree of N-Acetylation. Polymers 2011, 3, 1875–1901.
  16. Zamboulis, A.; Nanaki, S.; Michailidou, G.; Koumentakou, I.; Lazaridou, M.; Ainali, N.M.; Xanthopoulou, E.; Bikiaris, D.N. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers 2020, 12, 1519.
  17. Popa, L.; Ghica, M.V.; Dinu-Pîrvu, C.E.; Irimia, T. Chitosan: A good candidate for sustained release ocular drug delivery systems. In Chitin-Chitosan—Myriad Functionalities in Science and Technology; InTech: London UK, 2018; pp. 283–310.
  18. Dekamin, M.G.; Karimi, Z.; Latifidoost, Z.; Ilkhanizadeh, S.; Daemi, H.; Naimi-Jamal, M.R.; Barikani, M. Alginic acid: A mild and renewable bifunctional heterogeneous biopolymeric organocatalyst for efficient and facile synthesis of polyhydroquinolines. Int. J. Biol. Macromol. 2018, 108, 1273–1280.
  19. Matsumoto, Y.; Ishii, D.; Iwata, T. Synthesis and characterization of alginic acid ester derivatives. Carbohydr. Polym. 2017, 171, 229–235.
  20. Karmakar, S.; Manna, S.; Kabiraj, S.; Jana, S. Recent progress in alginate-based carriers for ocular targeting of therapeutics. Food Hydrocoll. Health 2022, 2, 100071.
  21. Reddy, S.G. Alginates—A Seaweed Product: Its Properties and Applications; IntechOpen: Rijeka, Croatia, 2021; Chapter 2.
  22. Panyamao, P.; Ruksiriwanich, W.; Sirisa-Ard, P.; Charumanee, S. Injectable Thermosensitive Chitosan/Pullulan-Based Hydrogels with Improved Mechanical Properties and Swelling Capacity. Polymers 2020, 12, 2514.
  23. Saeaeh, K.; Thummarungsan, N.; Paradee, N.; Choeichom, P.; Phasuksom, K.; Lerdwijitjarud, W.; Sirivat, A. Soft and highly responsive multi-walled carbon nanotube/pullulan hydrogel composites as electroactive materials. Eur. Polym. J. 2019, 120, 109231.
  24. Coltelli, M.-B.; Danti, S.; De Clerck, K.; Lazzeri, A.; Morganti, P. Pullulan for Advanced Sustainable Body- and Skin-Contact Applications. J. Funct. Biomater. 2020, 11, 20.
  25. Larrañeta, E.; Henry, M.; Irwin, N.J.; Trotter, J.; Perminova, A.A.; Donnelly, R. Synthesis and characterization of hyaluronic acid hydrogels crosslinked using a solvent-free process for potential biomedical applications. Carbohydr. Polym. 2018, 181, 1194–1205.
  26. Egbu, R.; Brocchini, S.; Khaw, P.T.; Awwad, S. Antibody loaded collapsible hyaluronic acid hydrogels for intraocular delivery. Eur. J. Pharm. Biopharm. 2018, 124, 95–103.
  27. Chang, W.-H.; Liu, P.-Y.; Lin, M.-H.; Lu, C.-J.; Chou, H.-Y.; Nian, C.-Y.; Jiang, Y.-T.; Hsu, Y.-H. Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses. Molecules 2021, 26, 2485.
  28. Cheng, Y.-H.; Ko, Y.-C.; Chang, Y.-F.; Huang, S.-H.; Liu, C.J.-L. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment. Exp. Eye Res. 2019, 179, 179–187.
  29. Campos, F.D.; Cassimiro, D.L.; Crespi, M.S.; Almeida, A.E.; Gremião, M.P. Preparation and characterisation of Dextran-70 hydrogel for controlled release of praziquantel. Braz. J. Pharm. Sci. 2013, 49, 75–83.
  30. Yao, Y.; Saw, P.E.; Nie, Y.; Wong, P.-P.; Jiang, L.; Ye, X.; Chen, J.; Ding, T.; Xu, L.; Yao, H.; et al. Multifunctional sharp pH-responsive nanoparticles for targeted drug delivery and effective breast cancer therapy. J. Mater. Chem. B 2018, 7, 576–585.
  31. Kilic Bektas, C.; Burcu, A.; Gedikoglu, G.; Telek, H.H.; Ornek, F.; Hasirci, V. Methacrylated gelatin hydrogels as corneal stroma substitutes: In vivo study. J. Biomater. Sci. Polym. Ed. 2019, 30, 1803–1821.
  32. Silva, S.S.; Fernandes, E.M.; Pina, S.; Silva-Correia, J.; Vieira, S.; Oliveira, J.M.; Reis, R.L. 2.11 Polymers of biological origin. Compr. Biomater. 2017, 2, 228–252.
  33. Bonetti, L.; De Nardo, L.; Farè, S. Thermo-Responsive Methylcellulose Hydrogels: From Design to Applications as Smart Biomaterials. Tissue Eng. Part B Rev. 2021, 27, 486–513.
  34. Thrimawithana, T.; Young, S.; Bunt, C.; Green, C.; Alany, R. In-vitro and in-vivo evaluation of carrageenan/methylcellulose polymeric systems for transscleral delivery of macromolecules. Eur. J. Pharm. Sci. 2011, 44, 399–409.
  35. Gupta, B.; Mishra, V.; Gharat, S.; Momin, M.; Omri, A. Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals 2021, 14, 1201.
  36. Kojima, N.; Tao, F.; Mihara, H.; Aoki, S. Methods for Engineering of Multicellular Spheroids to Reconstitute the Liver Tissue. In Stem Cells and Cancer in Hepatology; Academic Press: Cambridge, MA, USA, 2018; pp. 145–158.
  37. El-Feky, G.S.; Zayed, G.; Elshaier, Y.; Alsharif, F.M. Chitosan-Gelatin Hydrogel Crosslinked with Oxidized Sucrose for the Ocular Delivery of Timolol Maleate. J. Pharm. Sci. 2018, 107, 3098–3104.
  38. Wong, F.S.Y.; Tsang, K.K.; Chu, A.M.W.; Chan, B.; Yao, K.M.; Lo, A.C.Y. Injectable cell-encapsulating composite alginate-collagen platform with inducible termination switch for safer ocular drug delivery. Biomaterials 2019, 201, 53–67.
  39. Sun, J.; Lei, Y.; Dai, Z.; Liu, X.; Huang, T.; Wu, J.; Xu, Z.P.; Sun, X. Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma. ACS Appl. Mater. Interfaces 2017, 9, 7990–7999.
  40. Gaspar-Pintiliescu, A.; Stefan, L.M.; Anton, E.D.; Berger, D.; Matei, C.; Negreanu-Pirjol, T.; Moldovan, L. Physicochemical and Biological Properties of Gelatin Extracted from Marine Snail Rapana venosa. Mar. Drugs 2019, 17, 589.
  41. He, Z.; Xiong, L. Evaluation of Biological Properties of Collagen/Hyaluronic Acid Composite Scaffolds. Polym. Polym. Compos. 2013, 21, 457–462.
  42. Jain, E.; Hill, L.; Canning, E.; Sell, S.A.; Zustiak, S.P. Control of gelation, degradation and physical properties of polyethylene glycol hydrogels through the chemical and physical identity of the crosslinker. J. Mater. Chem. B 2017, 5, 2679–2691.
  43. Ma, A.; Yu, S.W.; Wong, J.K. Micropulse laser for the treatment of glaucoma: A literature review. Surv. Ophthalmol. 2019, 64, 486–497.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Polymer Science
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
KASSAHUN ALULA Akulo
,
Terin Adali
,
MTHABISI TALENT GEORGE MOYO
,
TÜLİN BODAMYALI
View Times: 614
Entry Collection: Biopharmaceuticals Technology
Revisions: 2 times (View History)
Update Date: 28 Jun 2022
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback